Verastem (NASDAQ: VSTM) reported Q4 EPS of ($0.37), may not compare to the analyst estimate of ($0.53). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $2.92 million.

For earnings history and earnings-related data on Verastem (VSTM) click here.